U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188701188701Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal CancerCompletedHas ResultsColorectal CancerRadiation: Radiation Therapy|Drug: Capecitabine 1650 mg/m^2/day|Drug: Capecitabine 1200 mg/m^2/day|Drug: Irinotecan|Drug: Oxaliplatin|Procedure: Surgery|Drug: Folinic Acid|Drug: Fluorouracil|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00081289
1887021887023-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerCompletedNo Results AvailablePrimary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial CancerDrug: triapine|Drug: cisplatin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00081276
188703188703Celecoxib in Treating Patients With Cervical Intraepithelial NeoplasiaActive, not recruitingNo Results AvailableCervical Cancer|Cervical Intraepithelial Neoplasia Grade 2|Cervical Intraepithelial Neoplasia Grade 3Other: hydrocortisone/placebo|Drug: celecoxibhttps://ClinicalTrials.gov/show/NCT00081263
188704188704Creatine in Treating Patients With Cancer-Associated Weight LossActive, not recruitingNo Results AvailableAnorexia|Cachexia|Unspecified Adult Solid Tumor, Protocol Specific|Weight ChangesDietary Supplement: creatine monohydrate|Other: placebohttps://ClinicalTrials.gov/show/NCT00081250
188705188705OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: OSI-7904L|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00081237
188706188706Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumCompletedNo Results AvailableColorectal CancerDrug: capecitabine|Drug: celecoxib|Radiation: radiation therapy|Procedure: surgeryhttps://ClinicalTrials.gov/show/NCT00081224
188707188707Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and NeckTerminatedNo Results AvailableRecurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|RecurrenBiological: PV701https://ClinicalTrials.gov/show/NCT00081211
188708188708Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the ProstateCompletedNo Results AvailableProstate CancerRadiation: lutetium Lu 177 monoclonal antibody J591https://ClinicalTrials.gov/show/NCT00081172
188709188709Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone MetastasesCompletedNo Results AvailableMetastatic Cancer|Prostate CancerDrug: Doxorubicin hydrochloride|Drug: Goserelin acetate|Drug: Leuprolide acetate|Drug: Zoledronic acid|Procedure: orchiectomy|Radiation: strontium chloride Srhttps://ClinicalTrials.gov/show/NCT00081159
188710188710Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaCompletedNo Results AvailableLeukemiaDrug: arsenic trioxide|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00081133
188711188711Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyCompletedNo Results AvailableLung CancerDrug: epothilone Dhttps://ClinicalTrials.gov/show/NCT00081107
188712188712Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerCompletedNo Results AvailableLiver CancerProcedure: 18F-Fluorodeoxyglucose-PET (FDG-PET)|Procedure: 11Carbon-Acetate-PEThttps://ClinicalTrials.gov/show/NCT00081094
188713188713Alemtuzumab in Treating Patients With Waldenstrom's MacroglobulinemiaWithdrawnNo Results AvailableLymphomaBiological: alemtuzumabhttps://ClinicalTrials.gov/show/NCT00081068
188714188714OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesWithdrawnNo Results AvailableGraft Versus Host Disease|Leukemia|Myelodysplastic SyndromesBiological: autologous expanded mesenchymal stem cells OTI-010|Drug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Drug: methotrexate|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00081055
188715188715ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Drug: paclitaxel albumin-stabilized nanoparticle formulationhttps://ClinicalTrials.gov/show/NCT00081042
188716188716Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced XerostomiaActive, not recruitingNo Results AvailableHead and Neck Cancer|Radiation Toxicity|XerostomiaProcedure: management of therapy complications|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00081029
188717188717Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast CancerCompletedNo Results AvailableBreast CancerGenetic: gene expression analysis|Genetic: protein expression analysis|Other: cytology specimen collection procedure|Other: laboratory biomarker analysis|Other: physiologic testing|Procedure: breast duct lavage|Procedure: endoscopic biopsy|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00081003
188718188718Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: alvocidib|Drug: fluorouracil|Drug: oxaliplatin|Drug: leucovorin calciumhttps://ClinicalTrials.gov/show/NCT00080990
188719188719High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2Active, not recruitingNo Results AvailableKidney CancerBiological: aldesleukinhttps://ClinicalTrials.gov/show/NCT00080977
188720188720Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00080951
188721188721Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung CancerCompletedHas ResultsLung Cancer|Metastatic CancerDrug: Temozolomide|Radiation: Radiation therapyhttps://ClinicalTrials.gov/show/NCT00080938
188722188722T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsBiological: filgrastim|Biological: graft-versus-tumor induction therapy|Biological: rituximab|Biological: therapeutic allogeneic lymphocytes|Drug: cyclophosphamide|Drug: cyclosporine|Drug: cytarabine|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: fludarabine phosphate|Drug: prednisone|Drug: vincristine sulfate|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00080925
188723188723Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone MetastasesCompletedHas ResultsMetastatic Cancer|PainRadiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00080912
188724188724Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerCompletedHas ResultsAdenocarcinoma of the Prostate|Recurrent Prostate CancerDrug: fenretinide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00080899
188725188725Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: rituximab|Drug: carmustine|Drug: cytarabine|Drug: etoposide|Drug: melphalan|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00080886
188726188726Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationCompletedNo Results AvailableKidney Cancer|Leukemia|Lymphoma|Neuroblastoma|Oral Complications|SarcomaDrug: Traumeel Shttps://ClinicalTrials.gov/show/NCT00080873
188727188727Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast CancerCompletedNo Results AvailableBreast CancerGenetic: microarray analysis|Other: immunohistochemistry staining method|Procedure: conventional surgery|Procedure: lymphangiography|Procedure: radionuclide imaging|Procedure: sentinel lymph node biopsy|Radiation: technetium Tc 99m sulfur colloidhttps://ClinicalTrials.gov/show/NCT00080860
188728188728S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's LymphomaTerminatedNo Results AvailableContiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell LymphomaBiological: oblimersen sodium|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: vincristine sulfate|Drug: prednisone|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00080847
188729188729DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal AdenocarcinomaCompletedNo Results AvailableColorectal CancerDrug: DJ-927https://ClinicalTrials.gov/show/NCT00080834
188730188730Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerCompletedNo Results AvailableProstate CancerDrug: Alprostadil (E1)|Drug: Papaverine|Drug: Phentolamine mesylate|Drug: Sildenafil citrate|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00080808

* Görseller ve İçerik tekif hakkına sahip olabilir